Suchergebnisse - "Levitan, Bennett"

PubPharm (121)

1

Quantitative Benefit-Risk Evaluation of Rivaroxaban in Patients After Peripheral Arterial Revascularization : The VOYAGER PAD Trial

enthalten in: Journal of the American Heart Association | 2024

von Yuan, Z. | Levitan, B. | Deng, H. | +6

2

A Benefit-Risk Conceptual Framework for Biologic Use During Pregnancy : A Mini-Review

enthalten in: Clinical pharmacology and therapeutics | 2024

von Bozzi, L. | Jacobson, M. | Yost, E. | +6

3

How to Present a Decision Object in Health Preference Research : Attributes and Levels, the Decision Model, and the Descriptive Framework

enthalten in: The patient | 2024

von Mühlbacher, A. | de Bekker-Grob, E. | Rivero-Arias, O. | +2

4

Benefit-risk assessment of vaccines

enthalten in: Vaccine | 2024

von Kochhar, S. | Izurieta, H. | Chandler, R. | +3

5

The Brighton collaboration standardized module for vaccine benefit-risk assessment

enthalten in: Vaccine | 2024

von Levitan, B. | Hadler, S. | Hurst, W. | +13

6

Current Practices and Challenges When Submitting Patient Experience Data for Regulatory Decisions by the US Food and Drug Administration : An Industry Survey

enthalten in: The patient | 2024

von Pinto, C. | Tervonen, T. | Jimenez-Moreno, C. | +5

7

Current Practices and Challenges When Submitting Patient Experience Data for Regulatory Decisions by the US Food and Drug Administration: An Industry Survey

enthalten in: The Patient | 2023

von Pinto, C. | Tervonen, T. | Jimenez-Moreno, C. | +5

8

Illustrating Emerging Good Practices for Quantitative Benefit-Risk Assessment : A Hypothetical Case Study of Systemic Biologic Treatments for Plaque Psoriasis

enthalten in: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | 2023

von Lackey, L. | Ng, X. | Veldwijk, J. | +5

9

Quantitative Benefit-Risk Assessment in Medical Product Decision Making : A Good Practices Report of an ISPOR Task Force

enthalten in: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | 2023

von Tervonen, T. | Veldwijk, J. | Payne, K. | +8

CommentIn: Value Health. 2023 Apr;26(4):447-448. - PMID 36720457

10

The relevance of fatigue to relapse rate in multiple sclerosis : Applying patient preference data to the OPTIMUM trial

enthalten in: Multiple sclerosis (Houndmills, Basingstoke, England) | 2023

von Fox, R. | Tervonen, T. | Phillips-Beyer, A. | +6

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[13]